Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 23 Gastrointestinal 19 Genitourinary 6 CNS 4 Thoracic 3 Sarcoma 3 Gynecologic 3 Other solid neoplasm 2 Tumor-Agnostic 1 Classical hematology 1

Conditions

Interventions

fludarabine phosphate 9 Cyclophosphamide 8 Cyclosporine 7 Busulfan 6 Antilymphocyte Serum 6 fludarabine 5 Melphalan 5 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Rivaroxaban 3 Radiotherapy 3 Methylprednisolone 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ferric carboxymaltose 2 apixaban 2 Whole-Body Irradiation 2 Therapeutics 2 Methotrexate 2 Heparin, Low-Molecular-Weight 2 Hematologic Tests 2 Genetic Counseling 2 Fondaparinux 2 Enoxaparin 2 Educational Status 2 Drug Therapy 2 Dalteparin 2 Cytarabine 2 sulforaphane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neoadjuvant Therapy × Classical hematology × Clear all

NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡